Peptide Blends
CagriSema (2.5mg+2.5mg)
CagriSema (2.5mg+2.5mg) — research-grade reference material, supplied in multiple sizes.
- Product Code
- CS
- Purity
- 99%
- Form
- Lyophilized powder
- Packaging
- 5mg*10vials
Ships from multiple warehouses — typically 2–5 business days to nearby destinations. International orders coordinated per destination.
No prices are published. Available scope, specifications and documentation are confirmed during specification review. Supplied for research and analytical use by qualified organizations — see our Research Use Only policy.
Specification
- Purity specification
- 99%
- Available sizes
- 5mg × 10vials
- Storage
- 2–8 °C, away from light and moisture
- MOQ
- On request
Research Applications
- A low-dose research combination of cagrilintide and semaglutide used to study the dose-response of combined amylin/GLP-1 agonism.
- Investigated for synergistic appetite suppression and energy-intake reduction in diet-induced metabolic models.
- Research applications include comparative studies of combination research applications vs. individual components on body weight and fat mass.
- Used in metabolic research to evaluate whether combined receptor activation improves tolerability while maintaining efficacy.
Cagrilintide + Semaglutide combination, synergistic metabolic-research effect
Related
Related solutions
Send us your specification
Share your sequence, format, packaging and documentation needs. Our team will review scope and next project steps.